Entering text into the input field will update the search result below

Shionogi says oral COVID-19 therapy rapidly cleared virus in mid-stage trial

Apr. 25, 2022 6:44 AM ETShionogi & Co., Ltd. (SGIOY) Stock, SGIOF StockBy: Dulan Lokuwithana, SA News Editor

Medication of antiviral capsule(medicine) for treatment and prevention of new corona virus infection(COVID-19,novel coronavirus disease 2019 or nCoV 2019 from Wuhan on mask.Pandemic infectious concept

sittithat tangwitthayaphum/iStock via Getty Images

Announcing new Phase 2b results for the company’s experimental COVID-19 therapy, S-217622, Japanese drugmaker Shionogi & Co. (OTCPK:SGIOY) (OTCPK:SGIOF) said that the once-daily oral treatment led to a rapid clearance of

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
SGIOF
--
SGIOY
--